使用个性化优势指数预测电疗法或胺之间的个人治疗分配
Benjamin S C Wade1, Ryan Pindale2, James Luccarelli2
1Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. bwade3@mgh.harvard.edu.
NPJ digital medicine
|February 27, 2025
概括
机器学习调整了个性化优势指数 (PAI) 来预测抑郁症的最佳治疗方法,将患者分配给电疗法 (ECT) 或胺. 这种方法有助于个性化抗抑郁药的选择,以获得更好的结果.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 计算生物学 计算生物学
背景情况:
- 电疗法 (ECT) 和胺是已知的抑郁症治疗方法.
- 缺乏基于证据的指导方针,阻碍了针对患者的最佳治疗选择.
- 需要个性化医疗方法来指导抗抑郁药治疗选择.
研究的目的:
- 使用机器学习调整个性化优势指数 (PAI),用于预测ECT和胺之间最佳的治疗分配.
- 为了确定预治疗因素,预测差异性治疗反应.
- 制定可操作的指导方针,以便在治疗抑郁症时在ECT和胺之间进行选择.
主要方法:
- 利用了2506名ECT和196名胺患者的电子健康记录 (EHR) 数据.
- 将PAI与机器学习模型进行调整,以预测最低抑郁症状得分 (min-QIDS).
- 对于392名患者 (每组为196人) 的雇员倾向性得分匹配,以控制混变量.
主要成果:
- 该PAI模型成功地预测了基于预处理EHR数据的差异性最小QIDS得分.
- SHAP值确定了影响治疗处方的治疗前关键因素.
- 与非最佳组相比,接受PAI预测的最佳治疗的患者显示出显著较低的min-QIDS (平均差异=1.19).
结论:
- 开发的机器学习模型可以预测ECT和胺之间的最佳抗抑郁药治疗选择.
- 确定的预治疗因素为临床决策提供了可操作的见解.
- 这种方法支持个性化治疗指南,以改善抑郁症管理.
更多相关视频
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
15.5K
04:51Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
9.3K
相关概念视频
01:30Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
01:24Kaplan-Meier Approach
75
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
75
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K